Christopher Downs - Chief Financial Officer at CNS Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
CNSP on Nasdaq
All Insider Reports
All Insider Reports

Christopher Downs - trading volume in the past year for CNS Pharmaceuticals, Inc.

Holdings reported by Christopher Downs for CNS Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common stock 103K $31K $0.30 Feb 1, 2024 Direct
Restricted Stock Units 242 $72.50 $0.30 Apr 8, 2024 Direct Common Stock
Series B Warrant to purchase common stock 162K Feb 1, 2024 Direct Common Stock
Series A Warrant to purchase common stock 94.9K Feb 1, 2024 Direct Common Stock
Option to purchase common stock 202 Apr 8, 2024 Direct Common Stock

Transactions reported by Christopher Downs for CNS Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.